Eptinezumab Safe, Effective for Migraine Prevention

A single dose of eptinezumab, which targets calcitonin gene-related peptide, provides rapid efficacy lasting up to 3 months in the prevention of chronic migraine, say PROMISE-2 investigators.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply